Combination approach prevents metastasis in mouse models.
Lab-generated lysate reduces metastasis, extends survival in animal models.
TERAVOLT consortium finds high mortality and barriers to treatment.
International registry begins to shed light on increased risk.
First evidence-based U.S. guidelines reflect a more diverse population.
Multi-part research initiative explores how RNA-containing EVs fuel cancer growth.
1 / 5
Creating continuity to help pediatric patients thrive into adulthood.
Study finds inhibiting WDR5 is a viable approach for MYC-driven cancers.
Phase 2 trial will test combination of cabozantinib and CB-839.